KKR & Co. (NYSE:KKR) has reached a deal to acquire Spectris (OTCPK:SEPJF), valuing the UK-based maker of precision instruments and testing software at approximately £4.1 billion ($5.6 billion ...

KKR was also involved in a bidding war for British healthcare real estate investor Assura, ... 7 Best Biotech Stocks to Buy for 2025. Analysts love these biotech stocks in 2025.

KKR & Co. agreed to buy Spectris Plc for £4.1 billion ($5.6 billion), surpassing an earlier bid for the British maker of precision testing equipment and software from a group led by Advent.

KKR makes £4.1bn offer to buy Spectris. The transaction implies an EV of around £4.7bn. Irien Joseph - 2 July 2025. Share A-A + 100%. London-based Spectris is a global precision measurement company; ...

Spectris (SEPJF) stock surged 5% as the UK firm backed KKR's improved £4.1B takeover bid, valuing shares at £40 and surpassing Advent's previous offer.